email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers


ISSN: 2637-4706

Drug Designing & Intellectual Properties International Journal

Mini Review(ISSN: 2637-4706)

Copper Complexes-A Alternative to Metallodrugs in Chemotherapy

Volume 3 - Issue 2

Ívina Paula de Souza*

  • Author Information Open or Close
    • Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Brazil

    *Corresponding author:Ívina Paula de Souza, Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Brazil

Received: August 02, 2019;   Published: August 09, 2019

DOI: 10.32474/DDIPIJ.2018.03.000157

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


The accidental discovery of cisplatin, cis-diaminodichloroplatinum (II), by Rosenberg and Van Camp in 1969, as a chemotherapeutic agent opened a new perspective by including metal complexes as possible antitumor agents [1,2]. Cisplatin was approved in the medical clinic, by Food and Drug Administration of the United States in 1978, and its importance in the treatment of various types of cancer, such as testicular, ovarian and pulmonary carcinoma is unequivocal [3,4]. However, the use of cisplatin has shown some limitations, such as the appearance of side effects, low solubility in water, and, especially, the development of cellular resistance [5,6]. The limitations in the treatment of neoplasic diseases with cisplatin have encouraged diverse research groups in the pursuit of other metal complexes, which should be more active and less toxic. An alternative would be replacing the metal center. In this context, copper complexes have shown to be an interesting alternative. Copper is an essential metallic ion that is involved in numerous biological process, playing an important role in diverse cellular function. In addition, copper may be less toxic for normal cells rather than to cancer cells [7,8]. The anoxic characteristic of cancer cells promotes the reduction of Cu(II) to Cu(I), which is not possible in normal cells. Cu(I) can catalyze the formation of reactive oxygen species (ROS) and induce lipidic peroxidation [9-11].

Keywords:Casiopeinas; Metallodrugs; Chemotherapy; Lipidic peroxidation; Phenathroline

Abstract| Mini Review| References|


Online Submission System

Drag and drop files here


Browse Files
( For multiple files submission, zip them in a single file to submit. For file zipping software Download )